Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
18.84B | 18.56B | 18.21B | 16.31B | 13.56B | 12.78B | Gross Profit |
5.68B | 5.47B | 5.50B | 5.32B | 4.73B | 4.23B | EBIT |
3.94B | 3.83B | 3.83B | 3.75B | 3.33B | 2.72B | EBITDA |
4.62B | 4.21B | 4.71B | 4.12B | 4.05B | 3.05B | Net Income Common Stockholders |
3.23B | 3.17B | 2.98B | 2.96B | 2.61B | 2.33B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.76B | 3.43B | 2.32B | 3.23B | 3.70B | 3.08B | Total Assets |
11.87B | 16.52B | 15.31B | 15.55B | 14.82B | 12.26B | Total Debt |
0.00 | 1.00B | 1.01B | 722.00M | 627.00M | 612.00M | Net Debt |
-2.36B | -771.00M | -471.00M | -1.58B | -2.75B | -1.85B | Total Liabilities |
2.55B | 5.92B | 6.09B | 5.56B | 4.32B | 3.56B | Stockholders Equity |
9.31B | 10.56B | 9.17B | 9.94B | 10.44B | 8.65B |
Cash Flow | Free Cash Flow | ||||
3.52B | 2.88B | 2.53B | 3.06B | 2.97B | 2.15B | Operating Cash Flow |
3.75B | 3.15B | 2.85B | 3.35B | 3.26B | 2.61B | Investing Cash Flow |
-265.07M | -708.00M | -218.00M | -1.00B | -1.13B | -242.00M | Financing Cash Flow |
-2.76B | -2.12B | -3.29B | -3.33B | -1.32B | -2.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $216.28B | 28.99 | 27.10% | 1.60% | 2.75% | 10.53% | |
75 Outperform | $80.41B | 24.69 | 29.99% | 2.10% | 3.08% | 11.92% | |
69 Neutral | $11.26B | 25.25 | 12.52% | ― | 0.80% | 10.05% | |
68 Neutral | $33.55B | 30.07 | 14.73% | 1.91% | -3.41% | 67.87% | |
67 Neutral | $1.27B | 22.42 | 5.71% | 0.38% | -6.34% | -0.89% | |
59 Neutral | $22.39B | 11.53 | -18.05% | 2.31% | 5.00% | -25.89% | |
47 Neutral | $3.26B | 267.98 | -2.51% | ― | -5.65% | 78.20% |